INTRODUCTION Toxicological
and biochemical re-examination of phthalate esters (PAEs) is needed since PAEs contamination is widely observed in our environment1), even in the blood of patients receiving hemodialysis treatment2,3) and di-2-ethylhexyl phthalate (DEHP) is a hepatocarcinogen in rats and mice4).
It is well known that orally administered PAEs are rapidly hydrolyzed to the corresponding monoesters, which are further metabolized to ketones and carboxylic acids via alcohols or to phthalic acid (PA) (cf. Lake et al.5) ).
In our previous paper6) we found that di-n-butyl phthalate (DBP) inhibited succinate and pyruvate dehydrogenases activities in rat liver mitochondria in vivo and in vitro experiments, suggesting that intact DBP also caused these inhibitions.
However, Lake et al. 5 ) suggested that any toxic effects of PAEs would be governed by the constituent phthalate monoesters and/or alcohols. So in the present work, to examine this idea, we compared the toxicological effects of orally administered DBP, monobutyl phthalate (MBP) and PA in rats. DEHP, which has undergone many experimental trials in rats, was also studied as a comparative material.
MATERIALS AND METHODS

Animals:
Five male Wistar rats were fed a powder diet containing DBP, MBP, PA or DEHP at a level of 0.5% or 5% for 34 to 36 days, respectively, as described previously6). As the experimental time differed with the compound, a control group was prepared for each compound experiment. Dehydrogenases and respiration activities in rat liver mitochondria: These activities in rat liver mitochondria were determined as described previously6). Serum biochemical tests : The tests were carried out using an autoanalyzer (Parallel, American Monitor Co.). Histological examinations : The liver, kidney and testicle were examined histologically by hematoxylin-eosin staining.
Ultrastructural examinations : Hepatocytes of the rats given a 5% diet of DBP and MBP were examined ultrastructurally by uranyl-lead staining.
RESULTS
Body weight, expressed as a percent of each control, decreased gradually in all groups except the PA group ( Fig. 1 ). Organ weights are shown in Table 1 . The relative weights of liver, kidney and spleen showed significant increases in the 5% diet group for DBP, MBP and DEHP, whereas the respective substances in the 0.5% diet group elicited almost no change. The testicle weight was markedly decreased in the 5% diet groups except for the PA group, but not in the 0.5% diet groups.
The succinate and pyruvate dehydrogenase activities in liver mitochondria were significantly inhibit- Table 1 Absolute and relative organ weights. Conditions were as described under the Materials and Methods. ed with a 5% diet of DBP, MBP, and DEHP ( Table 2 ). Such inhibitions were also observed at a 0.5% level of these compounds except for pyruvate dehydrogenase in the DEHP group. Glutamate dehydrogenate activity, however, was not affected in any of these groups. These results in mitochondria of DBP-treated rats corresponded well with our previous results6). PA showed no effects, even at a 5% level, on the activity of any of the enzymes.
The inhibitory effects of the compounds on succinate dehydrogenase activity were examined in vitro.
DBP significantly inhibited activity in correspondence with its concentration in good accord with our previous results6), whereas MBP and PA showed no inhibition (Table 3 ). MBP and PA had no effect on respiration (Table 4 ). DEHP had similar effects as DBP on respiration (Table 4 ). Serum biochemical results are shown in Table 5 . The activities of ALP, GOT and GPT increased in rats that received high doses of DBP or DEHP. Decreased globulin and increased A/G were observed in all groups except for the PA group. MBP at both the high and low doses resulted in decreased TG and uric acid.
Increased CPK activity was found in the DBP group.
Histopathological changes and numbers of rats with such changes are shown in Table 6 . The rats treated with DBP, MBP or DEHP revealed abnormal changes in the liver and testicles.
In the liver, cytotoxic injury including single cell necrosis, zonal necrosis and degeneration with balloning were observed in many of the rats that received high does of the compounds. Marked spermatogenic damage was seen in the testicles of the 5%-dose groups except for the PA group. 
DISCUSSION
It has been previously reported that animals given PAE evidenced growth depression, liver enlargement and testicular atrophy7-12). The rats in the present study also revealed these phenomena with a 5% diet of DBP, DEHP or MBP. The rats given a 0.5% diet of these compounds, however, did not revealed any such findings other than growth depression.
In the serum biochemical tests and light microscopic examinations, some different findings were observed between the treated rats and the controls, though they were slight in the rats with a 0.5% diet and unaltered in the rats with PA even with a 5% diet.
Comparing the effects of DBP and MBP, DBP was more effective than MBP on liver enlargement, It has been shown in vitro that the inhibitory action on the succinate dehydrogenase activity13) and mitochondria) respiration14) was more potent for DBP than MBP. Ariyoshi et al. 15 ) showed that the effect on the induction of the drug-metabolizing enzyme system in rat liver was more intensive for DBP than MBP when orally administered.
The findings in the present study that the adverse effects observed in rats given DBP were generally reproducible with MBP would support the suggestion by Lake et al.5) that any toxic effects of PAE would be governed by corresponding monoesters and/or alcohols. However, the finding that DBP administration was more effective than MBP suggests the existence of an additional action by DBP itself, apart from that of monoesters and/or alcohols. If the effects following oral administration of DBP were governed totally by MBP and/or alcohols derived from DBP, they would be rather slight compared with those following MBP administration at the same dose (food consumption was similar in both DBP and MBP groups).
Therefore, intact DBP entering the liver would be responsible for the development of additional hepatic effects. This idea could be supported by our recent unpublished finding that DBP-induced inhibition of succinate dehydrogenase in rat liver mitochondria in vitro was not reversed by washing of DBP-treated mitochondria. However, further studies on determination of DBP levels in mitochondria during the period of continuous feeding of DBP are required to confirm this idea. SUMMARY Rats were given a powder diet containing dibutyl phthalate (DBP), monobutyl phthalate (MBP), di-2-ethylhexyl phthalate (DEHP) or phthalic acid (PA) at a level of 0.5 or 5% for 34 to 36 days, respectively.
The rats treated with a 5% diet of DBP, MBP or DEHP revealed growth depression, liver enlargement, testicular atrophy, decreased activities of succinate and pyruvate dehydrogenases in liver mitochondria, and abnormal changes in biochemical tests of serum and in histological examinations of the liver and testicle. These adverse effects were also observed in rats fed a 0.5% diet of these compounds, although they were less severe. On the other hand, PA had no effect, even at a 5% concentration in the diet.
The changes in hepatocellular ultrastructure were more prominent in rats treated with DBP than in those given MBP. The most striking difference between DBP and MBP was that DBP showed a potent inhibitory effect on succinate dehydrogenase activity in liver mitochondria in vitro, wherease MBP showed no such effect. This difference was also observed in liver mitochondrial respiration in vitro.
It was suggested that the adverse effects of orally administered DBP at least on the liver may be caused partly by the direct action of intact DBP entering the liver.
